What is the Stem cell therapy for cardiac repair?

Introduction

Stem cell therapy has emerged as a promising approach for cardiac repair, particularly for treating ischemic heart diseases and myocardial infarction. This therapeutic strategy aims to regenerate damaged cardiac tissue, improve heart function, and reduce scar formation by utilizing various types of stem cells.

Key Insights

Pre-vascularized Stem Cell Patches:
- 3D printed pre-vascularized stem cell patches enhance therapeutic efficacy by promoting rapid vascularization, reducing cardiac hypertrophy and fibrosis, and improving overall cardiac function.
Intramyocardial Injection of Mesenchymal Stem Cells (MSCs):
- Direct injection of allogeneic MSCs into the myocardium post-myocardial infarction results in long-term engraftment, significant reduction in scar formation, and near-normalization of cardiac function .
Cardiac Stem/Progenitor Cells (CS/PCs) and Induced Pluripotent Stem Cells (iPSCs):
- Both CS/PCs and iPSCs can differentiate into cardiac lineages and have shown promise in animal models for cardiac repair. However, CS/PCs have advanced further in clinical applications due to fewer inherent obstacles compared to iPSCs.
Bone Marrow-Derived Stem Cells:
- Bone marrow-derived stem cells, including mononuclear cells and MSCs, have demonstrated potential in cardiac repair by differentiating into cardiac lineages and supporting angiogenesis .
Paracrine Effects and Exosomes:
- The beneficial effects of stem cell therapy may be mediated through paracrine factors, including growth factors, cytokines, and exosomes, which modulate cellular processes and promote cardiac repair.
Clinical Trials and Safety:
- Early clinical trials have shown that stem cell therapy is safe and can lead to modest improvements in cardiac function. Further well-designed trials are needed to establish its efficacy and optimize delivery methods .

Conclusion

Stem cell therapy holds significant promise for cardiac repair by utilizing various types of stem cells, including MSCs, CS/PCs, and iPSCs. Key strategies such as pre-vascularized stem cell patches, direct intramyocardial injection, and leveraging paracrine effects have shown potential in improving cardiac function and reducing scar formation. While early clinical trials indicate safety and modest efficacy, further research and well-designed clinical trials are essential to fully realize the potential of stem cell therapy in cardiac regenerative medicine.

What is the Stem cell therapy for cardiac repair?

Summary

Introduction

Key Insights

Conclusion

Sources and full results

3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair.

3D printed pre-vascularized stem cell patches can enhance cardiac repair by promoting rapid vascularization and tissue regeneration.

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction.

Intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction is safe and effective, reducing scar formation and near-normalizing cardiac function without rejection.

Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease.

Cardiac stem/progenitor cells have advanced more clinically for cardiac repair than induced pluripotent stem cells, but further studies are needed to advance cell therapy for heart disease treatment.

Cardiac regeneration and stem cell therapy

Recent advances in cardiac regeneration and stem-cell therapy show promise for cell-based cardiac repair, with promising clinical trials and mechanistic evaluations.

Mesenchymal Stem Cell Therapy for Cardiac Repair

Mesenchymal stem cell therapy shows promise for cardiac repair, but optimal delivery strategies and pretreatment strategies need further exploration.

Stem Cells and Cardiac Repair

Stem cell therapy shows promise in enhancing cardiac function after injury, but enhancing survival and engraftment is crucial for optimal repair.

Stem cell therapy for cardiac disease

Stem cell therapy shows promise for cardiac repair, with promising results in animal studies and early clinical trials, but further carefully designed trials are needed for mainstream acceptance.

Mesenchymal stem cell therapy for cardiac repair.

Mesenchymal stem cells show great promise in repairing damaged cardiac tissue, with unique properties and immune-modulating properties, offering a promising treatment option for heart failure patients.

Stem Cell Therapy and Congenital Heart Disease

Stem cell therapy shows promise for children with congenital heart disease, offering potential for cardiac repair and recovery, but more research is needed to confirm safety and efficacy.

Stem Cell Therapy for Cardiac Repair

Stem cell therapy shows potential for improving heart function after a myocardial infarction, but further research is needed to determine the appropriate cell source and mechanisms of improvement.

Try another search